We chose DataServ for P2P automation because of their reputation as a leader in streamlining AP workflow for companies of all sizes,
St. Louis, MO (PRWEB) April 13, 2016
DataServ, a global Software as a Service (SaaS) provider of document and process automation solutions, today announced that Triad Isotopes, Inc., the nation’s second largest radiopharmaceutical company, is using DataServ’s Purchase to Pay (P2P) solution to automate and streamline its accounts payable (AP) process.
Triad Isotopes will utilize the Expense Reporting component of DataServ’s P2P automation solution to institute better financial controls through defined workflow, audit capability, and improved visibility into their AP process.
“We chose DataServ for P2P automation because of their reputation as a leader in streamlining AP workflow for companies of all sizes,” says Audrey Houck, Corporate Controller for Triad Isotopes. “In addition to providing us with a paperless AP environment, DataServ will afford us significant savings by eliminating the expensive shipping charges we currently incur in sending receipts to our home office. Their solution will also aid us with sales/use tax compliance.”
Adds DataServ Founder/CEO Jeff Haller: “We are pleased to implement our P2P solution for Triad Isotopes, and we know that they will find our Expense Reporting component extremely valuable. Triad Isotopes is a thriving company that provides its customers with unparalleled service and the safest products, and DataServ is confident our AP automation solution will only add to Triad’s reputation for excellence and performance.”
DataServ is a global SaaS provider of document and process workflow automation for the financial operations and human resources functions. A cloud computing pioneer of FinTech solutions for Purchase to Pay (P2P) and Quote to Cash (Q2C), DataServ’s Open E-Invoicing is utilized by companies in 48 different countries.
About Triad Isotopes, Inc.
Triad Isotopes, Inc. (http://www.TriadIsotopes.com) is a nationwide nuclear pharmacy company headquartered in Orlando, Florida. The company’s national network of 55 locations serves four million patients each year, making Triad Isotopes the second-largest radiopharmaceutical provider in the United States. These specialized facilities provide the products used by hospitals and nuclear medicine operators to help diagnose and treat patients, primarily those with cardiac and cancer concerns.